BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10980636)

  • 1. Cytokines and hemostasis.
    Grignani G; Maiolo A
    Haematologica; 2000 Sep; 85(9):967-72. PubMed ID: 10980636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
    Mackman N; Tilley RE; Key NS
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1687-93. PubMed ID: 17556654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tissue factor as an antithrombotic strategy.
    Golino P; Cimmino G
    Semin Vasc Med; 2003 May; 3(2):205-14. PubMed ID: 15199484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intradermal tumor necrosis factor-alpha-induced inflammation on coagulation factors in dermal vessel endothelium. An in vivo study of human skin biopsies.
    Speiser W; Kapiotis S; Kopp CW; Simonitsch I; Jilma B; Jansen B; Exner M; Chott A
    Thromb Haemost; 2001 Feb; 85(2):362-7. PubMed ID: 11246561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
    Rak J; Klement P; Yu J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor vaccination: where we stand.
    Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S
    Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
    Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
    Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].
    Del Turco S; De Caterina R
    Ital Heart J Suppl; 2003 Jul; 4(7):559-68. PubMed ID: 14558284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trends in antithrombotic drug and device development.
    Fareed J
    Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tissue factor in hemostasis and thrombosis.
    Mackman N
    Blood Cells Mol Dis; 2006; 36(2):104-7. PubMed ID: 16466951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factor in cardiovascular disease pathophysiology and pharmacological intervention.
    Holy EW; Tanner FC
    Adv Pharmacol; 2010; 59():259-92. PubMed ID: 20933205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptor.
    Nadir Y; Katz T; Sarig G; Hoffman R; Oliven A; Rowe JM; Brenner B
    Haematologica; 2005 Nov; 90(11):1549-56. PubMed ID: 16266903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of tissue factor in cardiovascular disease.
    Jude B; Zawadzki C; Susen S; Corseaux D
    Arch Mal Coeur Vaiss; 2005 Jun; 98(6):667-71. PubMed ID: 16007822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.
    Vignoli A; Marchetti M; Balducci D; Barbui T; Falanga A
    Haematologica; 2006 Feb; 91(2):207-14. PubMed ID: 16461305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines.
    Szotowski B; Antoniak S; Poller W; Schultheiss HP; Rauch U
    Circ Res; 2005 Jun; 96(12):1233-9. PubMed ID: 15920023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in haemostasis and thrombosis.
    Vine AK
    Retina; 2009 Jan; 29(1):1-7. PubMed ID: 19050668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.